![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/5/57/Estron.svg/640px-Estron.svg.png&w=640&q=50)
Estrone/progesterone
Combination drug / From Wikipedia, the free encyclopedia
Estrone/progesterone (E1/P4), sold under the brand name Synergon, is a combination medication formulation of estrone, an estrogen, and progesterone, a progestogen. E1/P4 is used as an injectable preparation to induce withdrawal bleeding in women with non-pregnancy-related amenorrhea (absence of menstruation).[3][1][2][4] [5][6][7] It has also sometimes been used off-label as an abortifacient.[5][6][8] The medication comes in a three-ampoule pack, contains 1 mg estrone and 10 mg progesterone per ampoule, and is administered by intramuscular injection.[3][5][6][9] The usual dose of the medication is three injections, each two days apart, with the treatment duration not exceeding one week.[3] E1/P4 is or has been available in France, Monaco, and Turkey, as well as in some French-speaking African countries such as Benin and Cameroon.[1][2][4][10][6][8] The medication has been marketed since at least 1952.[11]
![]() | |
![]() | |
Combination of | |
---|---|
Estrone | Estrogen |
Progesterone | Progestogen |
Clinical data | |
Trade names | Synergon[1][2] |
Other names | E1/P4 |
Routes of administration | Intramuscular injection |